FIELD: medicine.
SUBSTANCE: present invention relates to decanoic acid or decanoic acid in the form of triglyceride for use in the treatment of epilepsy, wherein decanoic acid or decanoic acid in the form of triglyceride is used in a combination with perampanel or its pharmaceutically acceptable salt.
EFFECT: obtaining a combination for the treatment of epilepsy.
27 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY | 2018 |
|
RU2793246C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS BASED ON 1,2-DIHYDROPYRIDINE COMPOUNDS | 2019 |
|
RU2824582C2 |
| COMBINATION OF INHIBITOR FGFR AND INHIBITOR IGF1R | 2015 |
|
RU2715893C2 |
| COMBINATIONS | 2015 |
|
RU2715236C2 |
| METHODS OF TREATING DRAVET SYNDROME | 2018 |
|
RU2767661C2 |
| COMPOSITION FOR INHIBITING SYNTHESIS OF 5-HT2B AGONIST AND METHODS OF USE THEREOF | 2017 |
|
RU2746000C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING PROSTATE CANCER, USING BENZOHETEROCYCLIC COMPOUND AND METHOD FOR PREVENTING AND/OR TREATING PROSTATE CANCER | 2016 |
|
RU2705576C2 |
| COMBINATION THERAPY FOR TREATMENT OF MAMMARY GLAND CANCER | 2018 |
|
RU2764724C2 |
| PEPTIDE ANTAGONIST OF THE NMDA RECEPTOR | 2019 |
|
RU2716258C1 |
| CYCLOPROPYLPIPERIDINE GLYCINE TRANSPORTER INHIBITORS | 2005 |
|
RU2387644C2 |
